Brief: Hybrigenics Says End Of Recruitment Of Phase II Clinical Study Of Inecalcitol In Acute Myeloid Leukemia
18/07/2018 16:48
July 18 (Reuters) - Hybrigenics SA ALHYG.PA :
* END OF RECRUITMENT OF INTERNATIONAL PHASE II CLINICAL
STUDY OF
INECALCITOL IN ACUTE MYELOID LEUKEMIA
Source text for Eikon: ID:nNDL96ZnyP
Further company coverage: ALHYG.PA
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million